Table 2. Hazard ratios (95% CI) of cancer incidence, all-cause death, cancer death, and noncancer death by MET-min/week in men^a .

	MET-min/week				≥3.5 vs 0 MET-min/week
	0	3.5–1000	>1000	P for trend
	(n = 21 051)	(n = 5808)	(n = 4805)
Cancer incidence
Cases	1308	364	340
Rateb	9.3	8.9	8.9
Model 1	1.0	0.92 (0.81–1.04)	0.89 (0.79–1.01)	0.0465	0.90 (0.82–1.00)
Model 2	1.0	1.00 (0.84–1.13)	0.98 (0.84–1.13)	0.0030	0.99 (0.88–1.11)
All-cause death
Cases	1083	219	214
Rateb	8.2	5.6	6.8
Model 1	1.0	0.70 (0.60–0.81)	0.66 (0.56–0.76)	0.0013	0.68 (0.60–0.76)
Model 2	1.0	0.73 (0.62–0.87)	0.66 (0.55–0.79)	0.0081	0.70 (0.61–0.79)
Cancer death
Cases	539	99	122
Rateb	3.9	2.7	3.3
Model 1	1.0	0.66 (0.53–0.81)	0.79 (0.64–0.96)	0.1818	0.72 (0.62–0.85)
Model 2	1.0	0.72 (0.57–0.92)	0.78 (0.62–0.98)	0.4211	0.75 (0.63–0.90)
Noncancer death
Cases	544	120	92
Rateb	4.3	2.9	3.5
Model 1	1.0	0.74 (0.60–0.91)	0.52 (0.41–0.66)	0.0016	0.63 (0.53–0.75)
Model 2	1.0	0.75 (0.59–0.95)	0.54 (0.41–0.70)	0.0036	0.64 (0.53–0.78)

^aAdjusted for age, smoking status, alcohol intake, body mass index, hypertension, total cholesterol, and diabetes.

^bAge-adjusted rate (per 100 000 person years).

Model 1: Without exclusion of early cases (those occurring within 3 years of the starting point).

Model 2: After exclusion of early cases (those occurring within 3 years of the starting point).